# A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients

> **NCT07036419** · PHASE2,PHASE3 · RECRUITING · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 240 (estimated)

## Conditions studied

- Operative Sedation of Pediatric
- Operative Sedation of Adolescent Patients

## Interventions

- **DRUG:** Remimazolam Tosilate for injection
- **DRUG:** Propofol Injection

## Key facts

- **NCT ID:** NCT07036419
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-10
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07036419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07036419, "A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07036419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*